Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News BioCryst Pharmaceuticals Inc BCRX

Healthcare Biotechnology
BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BCRX)

BioCryst to Report First Quarter 2026 Financial Results on May 6

GlobeNewswire 2 days ago

BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer

GlobeNewswire 11 days ago

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire April 3, 2026

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire March 4, 2026

BioCryst Reports Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire February 26, 2026

BioCryst to Present at Upcoming Investor Conference

GlobeNewswire February 17, 2026

BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting

GlobeNewswire February 11, 2026

BioCryst to Report Fourth Quarter 2025 Financial Results on February 26

GlobeNewswire February 5, 2026

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 5, 2026
View More News ››

Opinion & Analysis (NDAQ:BCRX)

The Calandra Report: Blood in streets, rivers of fortune

Thom Calandra July 24, 2015

The Calandra Report: Rapivab, MERS, Thailand & BCRX

Thom Calandra June 19, 2015

The Calandra Report: Show me a favorite, I dare you

Thom Calandra June 8, 2015

The Calandra Report: Moveable feast of pharma, not gold

Thom Calandra June 4, 2015

The Calandra Report: They're jamming In the name of the lode

Thom Calandra March 13, 2015

Ultra-Actionables: Natcore Tech, Angkor Gold, BioCryst, Vegas

Thom Calandra February 20, 2015
View More Opinion ››

Bullboard Posts (NDAQ:BCRX)

4 PROMISING BIOTECH STOCKS WITH IMMENSE POTENTIAL!

$BCRX $IPSC $DYAI $CDNA   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of...
AviseAnalytics - January 14, 2022

BCRX LONG!

My largest holding   Awaiting Factor D news Mar 22.  This can be life changing.   
mevani - March 17, 2021

BOOM!!!!! eom

Now we are getting noticed.  Still holding my shares.
mevani - February 1, 2021

RE:RE:This is a long term hold for me

I have been accumulatig  BCRX since the $3's  up to and including the $9's  more recently.  Seems to have...
mevani - January 22, 2021

RE:This is a long term hold for me

    I have been accumulating on the dips.   Just a matter of time.
mevani - January 6, 2021

This is a long term hold for me

I haven't sold a single share and I will hold through 2021 until the catalysts play out.  The risk reward scenereo here is just...
mevani - December 8, 2020
View more Bullboard ››

Pasofino Gold Limited

Pasofino Gold Limited

Pasofino Gold Limited, a Canada-based mineral exploration company, engages in the acquisition, exploration, and development ...
View More »

Podcasts